EUVIMEDEUVIMED entdecken
Crossref

Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study

Haupts M, Klasser M, Faude U

Neurological Disorders and Therapeutics · 2018

DOI: 10.15761/ndt.1000129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Disorders and Therapeutics, 2018. Verfasst von Haupts M und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

M, H., M, K., & U, F. (2018). Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study. Neurological Disorders and Therapeutics. https://doi.org/10.15761/ndt.1000129

Vancouver

M H, M K, U F. Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study. Neurological Disorders and Therapeutics. 2018. doi:10.15761/ndt.1000129

BibTeX
@article{M2018,
  author = {M, Haupts and M, Klasser and U, Faude},
  title = {Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study},
  journal = {Neurological Disorders and Therapeutics},
  year = {2018},
  doi = {10.15761/ndt.1000129}
}
Kostenlos starten →